Literature DB >> 17373576

A total error approach for the validation of quantitative analytical methods.

David Hoffman1, Robert Kringle.   

Abstract

PURPOSE: Typical acceptance criteria for analytical methods are not chosen with regard to the concept of method suitability and are commonly based on ad-hoc rules. Such approaches yield unknown and uncontrolled risks of accepting unsuitable analytical methods and rejecting suitable analytical methods. This paper proposes a formal statistical framework for the validation of analytical methods, which incorporates the use of total error and controls the risks of incorrect decision-making.
MATERIALS AND METHODS: A total error approach for method validation based on the use of two-sided beta-content tolerance intervals is proposed. The performance of the proposed approach is compared to the performance of current ad-hoc approaches via simulation techniques.
RESULTS: The current ad-hoc approaches for method validation fail to control the risk of incorrectly accepting unsuitable analytical methods. The proposed total error approach controls the risk of incorrectly accepting unsuitable analytical methods and provides adequate power to accept truly suitable methods.
CONCLUSION: Current ad-hoc approaches to method validation are inconsistent with ensuring method suitability. A total error approach based on the use of two-sided beta-content tolerance intervals was developed. The total error approach offers a formal statistical framework for assessing analytical method performance. The approach is consistent with the concept of method suitability and controls the risk of incorrectly accepting unsuitable analytical methods.

Mesh:

Year:  2007        PMID: 17373576     DOI: 10.1007/s11095-007-9242-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.

Authors:  J W Findlay; W C Smith; J W Lee; G D Nordblom; I Das; B S DeSilva; M N Khan; R R Bowsher
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

2.  Workshop on bioanalytical methods validation for macromolecules: summary report.

Authors:  K J Miller; R R Bowsher; A Celniker; J Gibbons; S Gupta; J W Lee; S J Swanson; W C Smith; R S Weiner
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

3.  Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.

Authors:  W W Hauck; R Shaikh
Journal:  J Biopharm Stat       Date:  2001-11       Impact factor: 1.051

4.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

5.  An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progress and limitations.

Authors:  B Boulanger; P Chiap; W Dewe; J Crommen; Ph Hubert
Journal:  J Pharm Biomed Anal       Date:  2003-08-08       Impact factor: 3.935

6.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.

Authors:  Ph Hubert; J-J Nguyen-Huu; B Boulanger; E Chapuzet; P Chiap; N Cohen; P-A Compagnon; W Dewé; M Feinberg; M Lallier; M Laurentie; N Mercier; G Muzard; C Nivet; L Valat
Journal:  J Pharm Biomed Anal       Date:  2004-11-15       Impact factor: 3.935

Review 7.  Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.

Authors:  JoMarie Smolec; Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelly; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker; Vinod Shah; Ronald Bowsher; Anthony Mire-Sluis; John W A Findlay; Mary Saltarelli; Valerie Quarmby; David Lansky; Robert Dillard; Martin Ullmann; Stephen Keller; H Thomas Karnes
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

8.  Two-sided tolerance intervals for balanced and unbalanced random effects models.

Authors:  David Hoffman; Robert Kringle
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

9.  An assessment of the 4-6-20 rule for acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies.

Authors:  R O Kringle
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

  9 in total
  4 in total

1.  Statistical considerations for assessment of bioanalytical incurred sample reproducibility.

Authors:  David Hoffman
Journal:  AAPS J       Date:  2009-08-08       Impact factor: 4.009

2.  Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.

Authors:  Perrine Courlet; Susana Alves Saldanha; Matthias Cavassini; Catia Marzolini; Eva Choong; Chantal Csajka; Huldrych F Günthard; Pascal André; Thierry Buclin; Vincent Desfontaine; Laurent Arthur Decosterd
Journal:  J Mass Spectrom       Date:  2020-03-11       Impact factor: 1.982

3.  Reproducibility of antimicrobial test methods.

Authors:  Albert E Parker; Martin A Hamilton; Darla M Goeres
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

4.  Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.

Authors:  Dany Spaggiari; Vincent Desfontaine; Sandra Cruchon; Sylvie Guinchard; Anthony Vocat; Emilyne Blattes; Jeff Pitteloud; Lorenzo Ciullini; Carine Bardinet; Anton Ivanyuk; Vadim Makarov; Olga Ryabova; Thierry Buclin; Stewart T Cole; Laurent A Decosterd
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.